Dr Rick Watson
UMIP’s New Projects Team welcomes Dr Rick Watson as Team Leader. Rick started his role in July this year and sees him supporting the efforts of the team to engage with academic innovators, identify IP and assess it for protection and onward commercialisation by UMIP.
Prior to working at UMIP Rick spent time working in several organisations at the Academic -Commercial interface including Manchester Business Growth Hub, as a consultant in the specialist Technology Transfer company Novomodo Ltd, and previous roles as Senior Innovation Consultant assisting company clients across the UK.
A former technology transfer manager at the University of Salford, Rick’s background is a mixture of different technologies including roles in Biotechnology community in Manchester and Scotland, time at The University of Strathclyde’s Forensic Science Unit, PhD research in Pharmaceutical Sciences at The University of Nottingham, and reading his first degree at Hull University in Chemistry with Analytical Chemistry and Toxicology.
Rick comments: “I am thrilled to join the UMIP team and to be working with such dedicated and talented professionals. I look forward to building on UMIP’s success and working with University colleagues to support their activities in IP commercialisation to generate revenue and research impact.”
Rick takes over from Dr Arnaud Garçon who has moved into UMIP’s IP Development and Partnering Team.
University of Cambridge IfM: Open Innovation Forum Food & FMCG Pitching Event – Amsterdam, November 2017
Senior leaders from major food and FMCG firms such as Mars, Heineken, PepsiCo, Suntory and General Mills are holding a pitching event for innovative companies, entrepreneurs, start-ups and university spin-offs. These companies, who are members of the Institute for Manufacturing’s Open Innovation (OI) Forum, are seeking new solutions to their business challenges, so you have the chance to pitch to them at an event hosted by Heineken and held on 16 November at the Heineken Experience, Amsterdam.
The 6th Food & FMCG Innovation Pitching Event is open to all individuals, research centres and companies of all sizes and levels of maturity. Up to 15 researchers, innovators and technology developers will be picked to pitch their ideas to a panel of key decision-makers and ‘innovation scouts’ from important food and FMCG firms (see full list here). However, all proposed pitches will be circulated to OI Forum members, whether they are shortlisted or not.
Ideas presented should specifically address one or more of the Forum’s business needs identified in the ‘Innovation Needs’ list and may fall within one of the following categories:
- Marketing and business models – including consumer insights, social media, digital marketing and new business models.
- Packaging – including interactive packaging, customised and novel packaging and materials.
- Ingredients – health, food safety, preservatives and synthetic biology.
- Manufacturing – including customisation, batch-of-one and novel food processing.
The event is free to enter and winners will receive a certificate and trophy, as well as the chance to present their ideas and products in front of senior leaders and decision-makers whose main job role is to scout for and acquire innovation and technology from outside their organisations.
The deadline for requesting a pitch is 20 October 2017. The most promising entry submitted by 30 September from an individual, start-up or SME will receive funding* towards transport costs to Heineken Experience in Amsterdam.
For more information and to enter the competition visit: http://www.ifm.eng.cam.ac.uk/events/oipitching17/
* Up to a maximum of £250. Further information on terms and conditions will be available from the event organisers.
An exclusive licence deal has been transacted by The University of Manchester’s technology transfer company (UMI3 Ltd) with Arriani Pharmaceuticals for a research tool which boosts the understanding of senescent cells role in diverse age-related diseases including cancer.
Professors Vassilis Gorgoulis and Paul Townsend are behind the universally applicable method, called SenTraGorΤΜ, which enables better detection of senescence (the aging of cells).
Professor Townsend described the licence as “ground-breaking” and said: “Cellular senescence is causally linked to ageing and has been implicated in a variety of age-related diseases such as cancer.
“But up to now, detecting senescence was problematic and infeasible in most widespread biological material.
The agreement will see Arriani provide SenTraGorΤΜ to research institutions, diagnostic labs, clinics and companies looking for new therapies and offering wider well-being services to the public. Harry Lambridis, President and Founder of Arriani comments: “We are proud to offer to the international scientific community the valuable outcome of the research conducted by Professors Vassilis Gorgoulis and Paul Townsend that will revolutionalise the detection of senescent cells. We strongly believe that SenTraGorΤΜ will greatly contribute in the understanding of age-related biological processes and to this end we will work closely with the Professors to enlarge the applications of SenTraGorΤΜ, even beyond this field.”
The University of Manchester’s Professor Paul Townsend and Honorary Professor Vassilis Gorgoulis are world experts in cancer biology.
Professor Townsend said the agreement will bring considerable benefits to research and clinical practice and even beyond that around the world.
“Our method provides unheard-of advantages over any other available senescence detection products,” he said.
“It’s widely applicable, straight forward and specific. It will also help researchers make new breakthroughs into the causes of diseases, including cancer, as there will be a more effective understanding of phenomenon of cellular senescence. Moreover, its application can be expanded even to the cosmetics and food industries.”
Professor Gorgoulis added: “SenTraGorΤΜ revolutionizes the field of cellular aging and opens the door to a better understanding and treatment of various disorders. Many cancer types, degenerative diseases, even infertility, are thought to be senescence-related and our method introduces a powerful weapon in the medical armory against these conditions.”
Dr Rich Ferrie, Director of Operations at UMIP, commented: “We are delighted to have secured this licence deal with our new partners, Arriani. The strong commercial team at Arriani will ensure that this exciting product is quickly rolled out internationally and we are confident that the relationship we have established together will be both successful and enduring.”
Networking in the Street
An event to showcase some of the start-ups being supported through UMIP’s (The University of Manchester’s technology transfer office) Innovation Optimiser has been held for the first time in UMIC’s Conference and Events space in the Core Technology facility on Grafton Street.
UMIP’s Enterprise team held the inaugural Showcase to highlight some of the fantastic businesses and innovations being developed by staff, academics and research students at The University of Manchester.
More than 75 entrepreneurs, colleagues from The University of Manchester and wider support partners gathered to learn how enterprises have benefitted from the support provided by the Innovation Optimiser and network over a celebratory Afternoon Tea.
Ten start-ups have successfully graduated through the programme this year – including ViewItUK Ltd, Urban Chain Ltd, Galivantes Ltd, Manchester Star Tuition Ltd, Fold-Out Publishing Ltd, EnviroSAR Ltd, Citizens Juries CIC, Cable Coatings Ltd, Affigo CIC and Artemis Analytical Ltd.
Director of Innovation Optimiser Tony Walker said: “Ten start-up businesses have passed through the Innovation Optimiser programme in 2017, which shows what a success it has already become.
“What’s fantastic is that so many people from many different backgrounds joined together at our inaugural Showcase event.”
Tom McNamara of FreeUp Ltd
He added: “We heard from a great range of entrepreneurs with different business concepts, all of whom are at different stages of their start-up journey, including; Tom McNamara of FreeUp Ltd, Dr Duncan Thomas, who runs Green Island Friends, Meera Dulabh from Neurolytics Ltd, James Adams of Cancer Awareness in Teenagers and Young People Society (CATS), Dr Gail Millin-Chalabi of EnviroSAR Ltd, and Professor Michael Donmall of ViewItUK Ltd. Some are still in the Ignition phase of exploring their ideas, whereas others have progressed through to our Momentum programme and have set up their business.”
“Our entrepreneurs gave both an insight into their companies and how our wide range of support has helped them progress, including some of the challenges they’ve faced. We’re always looking for new ways to support our businesses and introduce them to potential partners.”
The Innovation Optimiser, which provides support for aspiring entrepreneurs wishing to develop start-up businesses, social ventures and research student enterprises, through educational resources and agile mentoring, was developed by UMIP in 2014 to complement its renowned Intellectual Property (IP) commercialisation activity. It provides a vibrant and supportive environment for individuals or teams with an idea, innovation or venture in which they are empowered to develop and build their business.
Professor Luke Georghiou and UMIP’s Dr Laura Etchells
Along with Tony Walker, Professor Luke Georghiou, Vice President of Research & Innovation at The University of Manchester, also spoke at the Showcase, emphasising the importance of supporting staff, academics and research students who may have an idea for a commercial start-up or social enterprise.
Professor Georghiou commented: “There was a buzz inside and outside the room and I greatly enjoyed hearing about the entrepreneurial experiences. It seems they are being well-prepared but as ever there is a need for many of them to connect with the right kind of finance if their businesses are to grow.”
Professor Vikas Shah, TiE UK North
Professor Vikas Shah, a well-known Manchester entrepreneur, President of TiE UK North, Honorary Professor at the Alliance Manchester Business School and partner to UMIP’s Innovation Optimiser, also spoke at the event, highlighting the support that TiE brings to UMIP’s budding entrepreneurs.
Ellie Buckley, UMIP Enterprise Development Executive and event organiser commented: “We’ve received phenomenal feedback from everyone who attended the Showcase. It really gave our entrepreneurs a prime opportunity to celebrate what they’ve achieved and make some great connections. We’re very excited about making the event bigger and better next year.”
To find out more, contact one of the Innovation Optimiser team:
Ellie Buckley, Enterprise Development Executive firstname.lastname@example.org or 0161 606 7265
Laura Etchells, Enterprise Development Manager email@example.com or 0161 606 7264
Tony Walker, Director of Innovation Optimiser, firstname.lastname@example.org or 0161 603 7780
The second lecture in the nanomedicine lecture series, to be held on Thursday, 9 November 2017 in the Core Technology Facility Dalton Room, will focus on nanotechnology in neurology and neurosciences, exploring the bridge between technology and neuroscience.
The following pre-eminent global leaders in biomedical science will be keynote speakers at this event:
- Professor Dame Nancy Rothwell, President and Vice-Chancellor of The University of Manchester
- Professor Ed Boyden, Associate Professor, Media Lab and McGovern Institute, Departments of Biological Engineering and Brain and Cognitive Sciences Co-Director, MIT Centre for Neurobiological Engineering
- Professor John Hardy, University College London
Please register via Eventbrite: https://www.eventbrite.co.uk/e/nanomednetwork-lecture-series-2-nanotechnology-in-neurologyneurosciences-tickets-34568005836
Please contact Sarah Barton (email@example.com) in the FBMH Strategic Funding Team with any queries.
About the NanoMed Network:
The University of Manchester NanoMed Network is a cross-faculty interdisciplinary network that aims to facilitate the exploitation of novel nanomaterials and nanotechnologies, such as graphene and other 2D materials, in order to provide solutions for unmet clinical challenges.
NanoMed Network website.